Ingestible compositions comprising antibacterial agents

David Blake; Cliff Stevens; Robert Eisenthal; Roger Harrison; Timothy Marc Miller; Edwards  Rachel

Ingestible compositions comprising antibacterial agents

David Blake (Inventor), Cliff Stevens (Inventor), Robert Eisenthal (Inventor), Roger Harrison (Inventor), Timothy Marc Miller (Inventor), Edwards Rachel (Inventor)

Research output: Patent

Abstract

A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

Original language	English
Patent number	US2004120938 (A1)
IPC	A23C9/12
Publication status	Published - 24 Jun 2004

Cite this

@misc{e56ffb04618d4a30a59cd4654e1c32e7,

title = "Ingestible compositions comprising antibacterial agents",

abstract = "A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a {"}natural antibiotic{"} to prevent or reduce bacterial infection within the gut, especially the neonatal gut.",

author = "David Blake and Cliff Stevens and Robert Eisenthal and Roger Harrison and Miller, {Timothy Marc} and Edwards Rachel",

year = "2004",

month = jun,

day = "24",

language = "English",

type = "Patent",

note = "US2004120938 (A1); A23C9/12",

}

TY - PAT

T1 - Ingestible compositions comprising antibacterial agents

AU - Blake, David

AU - Stevens, Cliff

AU - Eisenthal, Robert

AU - Harrison, Roger

AU - Miller, Timothy Marc

AU - Rachel, Edwards

PY - 2004/6/24

Y1 - 2004/6/24

N2 - A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

AB - A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

M3 - Patent

M1 - US2004120938 (A1)

ER -

Ingestible compositions comprising antibacterial agents

Abstract

Fingerprint

Cite this